Clifford Chance advises on Arrail Group's Hong Kong IPO and Listing
22 March 2022
Clifford Chance advises on Arrail Group's Hong Kong IPO and Listing
Leading international law firm Clifford Chance has advised Morgan Stanley, UBS and other underwriters on Arrail Group Limited's approximately US$87 million initial public offering and listing on the Hong Kong Stock Exchange. Arrail Group is the largest player in the premium private dental service market in China.
Partners Fang Liu and Virginia Lee co-led the deal, with support from counsel Claire Cao, senior associate Erxin Lu, associates Hongzhou Chen, Ada Zheng, trainees Yuqing Liu, Jingyi Zhang and Ruonan Tang in Beijing.
Fang Liu commented, "This is the first leading dental service brand to be listed in Hong Kong. It demonstrates that medical clinic chains, an important segment in the healthcare service sector, have become increasingly active in the capital markets."
Clifford Chance regularly advises on leading healthcare service companies' IPOs, such as Hygeia Healthcare, Ping An Good Doctor and Hospital Corporation of China Limited.
高伟绅助力瑞尔集团香港首次公开发行及上市
国际领先律师事务所高伟绅就瑞尔集团有限公司约8,700万美元首次公开发行和香港联交所上市,为摩根士丹利、瑞银及其他承销商提供法律服务。瑞尔是中国最大的高端民营口腔医疗服务集团。
高伟绅香港办公室合伙人方刘和李婉雯律师共同牵头本交易,北京办公室曹阳、陆尔馨、陈虹州、郑喻丹、刘雨晴、张静怡和唐若楠等律师提供支持。
方刘律师表示:“这是首家中国领先的口腔医疗服务品牌在港上市。作为医疗健康服务领域的重要赛道,连锁诊所运营在资本市场愈加活跃。”
高伟绅市场领先的大中华区上市业务团队经常为前沿医疗健康服务企业的首次公开发行提供服务,包括之前的海吉亚医疗、平安好医生以及弘和仁爱医疗。